Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Willow Biosciences Inc. (C:WLLW)

Business Focus: Biopharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for WLLW within the last 6 months
See all filings within the past 6 months

Company News

Jan 15, 2020 13:35 ET
Willow Biosciences Inc. Opens the Market
TORONTO, Jan. 15, 2020 /CNW/ - Trevor Peters, President, Chief Executive Officer and Director, Willow Biosciences Inc. (WLLW), joined Dani Lipkin, Innovation Sector Head, Capital Formation, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow Biosciences Inc. commenced trading on Toronto Stock Exchange on December 5, 2019.
Read full article
Dec 03, 2019 16:04 ET
Willow Biosciences Announces Trading Date on the Toronto Stock Exchange
CALGARY, Dec. 3, 2019 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it has received final approval from the Toronto Stock Exchange (the "TSX") to list its common shares (the "Common Shares") on the TSX.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 30, 201911,706-34,144
Nov 15, 201945,850-2,925
Oct 31, 201948,775-44,225
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Willow Biosciences Inc., formerly Makena Resources Inc., is a Canada-based research and development company. The Company is focused on creating synthetic biology solution from gene discovery to cannabinoid commercialization.

See business summary


Search (past week) for $WLLW.CA